Alzheimer’s disease is commonly thought of as an older person’s illness. But new research from Columbia University and the ...

People with Alzheimer's disease may retain their ability to empathize, despite declines in other social abilities, finds a ...

A team of scientists including UCL researchers has tested four anti-amyloid Alzheimer's therapeutics to find out how the ...

People with Alzheimer's disease may retain their ability to empathize, despite declines in other social abilities, finds a new study.

A new study suggests that risk factors and biomarkers related to Alzheimer's disease are associated with cognition much earlier in life than previously recognized. The study highlights significant ...

The total economic burden of Alzheimer's disease and related dementias in the United States will reach $781 billion this year ...

People with Alzheimer's disease may retain their ability to empathise, despite declines in other social abilities, finds a ...

Metabolic syndrome is linked to greater risk of developing young-onset dementia, according to a new study. But there are ...

A commonly prescribed sleeping pill could be a powerful tool in preventing Alzheimer's disease, according to recently ...

Across nearly 2 million people with a mean age of 49, metabolic syndrome was tied to a 24% higher risk of all-cause ...

A new study reveals that cognitive changes tied to Alzheimer's risk factors begin far earlier in life than previously thought ...

A randomized, placebo-controlled clinical trial is underway called Valacyclovir Treatment of Alzheimer’s Disease but results ...